During the past decade, Minimally Invasive Surgery Hospital conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 27 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 27 clinical trials were completed. i.e. 540% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minimally Invasive Surgery Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Gynecologic Oncology Group" with 7 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minimally Invasive Surgery Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Minimally Invasive Surgery Hospital" are "Invasive Breast Carcinoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IIIA Breast Cancer" (5 trials), "HER2/Neu Negative" (4 trials) and "Recurrent Squamous Cell Lung Carcinoma" (4 trials). Many other conditions were trialed in "Minimally Invasive Surgery Hospital" in a lesser frequency.

Most popular intervention types in "Minimally Invasive Surgery Hospital" are "Drug" (54 trials), "Other" (47 trials), "Biological" (25 trials), "Procedure" (16 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (16 trials), "Biospecimen Collection" (8 trials), "Computed Tomography" (8 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Minimally Invasive Surgery Hospital" are 63 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Minimally Invasive Surgery Hospital". undefined are not yet recruiting, 9 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Minimally Invasive Surgery Hospital, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Minimally Invasive Surgery Hospital, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Minimally Invasive Surgery Hospital has several departments that took part in Clinical trials: "Kansas Institute of Medicine Cancer and Blood Center" - 74 trials